Cargando…

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer

BACKGROUND: To improve the prognosis of patients with pancreatic cancer, new biomarkers are required for earlier, pre-symptomatic diagnosis. Epigenetic mutations take place at the earliest stages of tumorigenesis and therefore offer new approaches for detecting and diagnosing disease. Nucleosomes ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauden, Monika, Pamart, Dorian, Ansari, Daniel, Herzog, Marielle, Eccleston, Mark, Micallef, Jake, Andersson, Bodil, Andersson, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597435/ https://www.ncbi.nlm.nih.gov/pubmed/26451166 http://dx.doi.org/10.1186/s13148-015-0139-4

Ejemplares similares

Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2023)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)

Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
por: Ansari, Daniel, et al.
Publicado: (2018)

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
por: Rahier, Jean-François, et al.
Publicado: (2017)

Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
por: Cavalier, Etienne, et al.
Publicado: (2021)

A novel proteomics approach to epigenetic profiling of circulating nucleosomes
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2021)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Safety of pancreatic resection in the elderly: a retrospective analysis of 556 patients
por: Ansari, Daniel, et al.
Publicado: (2016)

Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury
por: Akbarshahi, Hamid, et al.
Publicado: (2012)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Organoid technology for personalized pancreatic cancer therapy
por: Bengtsson, Axel, et al.
Publicado: (2021)

Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017)

Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
por: Zhou, Qimin, et al.
Publicado: (2019)

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
por: Zhou, Qimin, et al.
Publicado: (2020)

Pancreatic cancer screening in high-risk individuals with genetic susceptibility
por: Andersson, Roland, et al.
Publicado: (2023)

Circulating nucleosomes as predictive markers of severe acute pancreatitis
por: Penttilä, Anne K., et al.
Publicado: (2016)

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)

CODUSA - Customize Optimal Donor Using Simulated Annealing In Heart Transplantation
por: Ansari, Daniel, et al.
Publicado: (2013)

Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
por: Byrling, J., et al.
Publicado: (2021)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
por: Bengtsson, Axel, et al.
Publicado: (2020)

SDPS-13 CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA
por: Decarpentrie, Jonathan, et al.
Publicado: (2023)

Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database
por: Sahlström, Emil, et al.
Publicado: (2020)

SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
por: Vaz, Juan, et al.
Publicado: (2015)

Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
por: Byrling, Johannes, et al.
Publicado: (2017)

Proteomic and genomic profiling of pancreatic cancer
por: Ansari, Daniel, et al.
Publicado: (2019)

Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis
por: Torén, William, et al.
Publicado: (2018)

Early-onset pancreatic cancer: a population-based study using the SEER registry
por: Ansari, Daniel, et al.
Publicado: (2019)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
por: Morimont, Laure, et al.
Publicado: (2022)

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures
por: Ungerer, Vida, et al.
Publicado: (2021)

Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer
por: Wilson-Robles, Heather, et al.
Publicado: (2020)

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
por: Gezer, Ugur, et al.
Publicado: (2015)

Prevention of Pleural Adhesions by Bioactive Polypeptides - A Pilot Study
por: Åkerberg, D., et al.
Publicado: (2013)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5es5ug8bi11j3678fum9vscocj